20 YEARS OF 131IODINE-METAIODOBENZYLGUANIDINE (131I-MIBG) THERAPY UPFRONT: A RETROSPECTIVE ANALYSIS OF ACUTE TOXICITY

被引：0
|
作者：
Bleeker, Gitta [1 ]
Schoot, Reineke [1 ]
Caron, Huib [1 ]
van Eck, Berthe
de Kraker, Jan [1 ]
Tytgat, Godelieve [1 ]
机构：
[1] Emma Childrens Hosp AMC, Amsterdam, Netherlands
来源：
PEDIATRIC BLOOD & CANCER | 2009年 / 53卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：736 / 736
页数：1
相关论文
共 50 条
  • [1] Toxicity of upfront 131I-metaiodobenzylguanidine (131I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis
    Bleeker, Gitta
    Schoot, Reineke A.
    Caron, Huib N.
    de Kraker, Jan
    Hoefnagel, Cees A.
    van Eck, Berthe L.
    Tytgat, Godelieve A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (11) : 1711 - 1717
  • [2] Toxicity of upfront 131I-metaiodobenzylguanidine (131I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis
    Gitta Bleeker
    Reineke A. Schoot
    Huib N. Caron
    Jan de Kraker
    Cees A. Hoefnagel
    Berthe L. van Eck
    Godelieve A. Tytgat
    European Journal of Nuclear Medicine and Molecular Imaging, 2013, 40 : 1711 - 1717
  • [3] Iodine-131 metaiodobenzylguanidine (131I-mIBG) treatment in relapsed/refractory neuroblastoma
    Anongpornjossakul, Yoch
    Sriwatcharin, Wattanun
    Thamnirat, Kanungnij
    Chamroonrat, Wichana
    Kositwattanarerk, Arpakorn
    Utamakul, Chirawat
    Sritara, Chanika
    Chokesuwattanasakul, Payap
    Thokanit, Nintita Sripaiboonkij
    Pakakasama, Samart
    Anurathapan, Usanarat
    Pongphitcha, Pongpak
    Chotipanich, Chanisa
    Hongeng, Suradej
    NUCLEAR MEDICINE COMMUNICATIONS, 2020, 41 (04) : 336 - 343
  • [4] THE ROLE OF 131I-METAIODOBENZYLGUANIDINE (131I-MIBG) THERAPY IN UNRESECTABLE AND COMPROMISING LOCALIZED NEUROBLASTOMA
    Schoot, Reineke
    Bleeker, Gitta
    Heij, Hugo
    van Eck, Berthe
    Caron, Huib
    de Kraker, Jan
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 807 - 808
  • [5] Pinhole imaging of 131I-metaiodobenzylguanidine (131I-MIBG) in an animal model of neuroblastoma
    Roberto Accorsi
    Michael J. Morowitz
    Martin Charron
    John M. Maris
    Pediatric Radiology, 2003, 33 : 688 - 692
  • [6] The treatment of malignant pheochromocytoma with Iodine-131 metaiodobenzylguanidine (131I-MIBG): A comprehensive review of 116 reported patients
    Keh-Chuan Loh
    P. A. Fitzgerald
    K. K. Matthay
    P. P. B. Yeo
    D. C. Price
    Journal of Endocrinological Investigation, 1997, 20 : 648 - 658
  • [7] Different outcomes for relapsed versus refractory neuroblastoma after therapy with 131I-metaiodobenzylguanidine (131I-MIBG)
    Zhou, Margaret J.
    Doral, Michelle Y.
    DuBois, Steven G.
    Villablanca, Judith G.
    Yanik, Gregory A.
    Matthay, Katherine K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (16) : 2465 - 2472
  • [8] 131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma:: a mono-institutional experience with 43 patients
    Garaventa, A
    Bellagamba, O
    Lo Piccolo, MS
    Milanaccio, C
    Lanino, E
    Bertolazzi, L
    Villavecchia, GP
    Cabria, M
    Scopinaro, G
    Claudiani, F
    De Bernardi, B
    BRITISH JOURNAL OF CANCER, 1999, 81 (08) : 1378 - 1384
  • [9] 131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients
    A Garaventa
    O Bellagamba
    M S Lo Piccolo
    C Milanaccio
    E Lanino
    L Bertolazzi
    G P Villavecchia
    M Cabria
    G Scopinaro
    F Claudiani
    B De Bernardi
    British Journal of Cancer, 1999, 81 : 1378 - 1384
  • [10] Thyroid and Hepatic Function After High-Dose 131I-Metaiodobenzylguanidine (131I-MIBG) Therapy for Neuroblastoma
    Quach, Alekist
    Ji, Lingyun
    Mishra, Vikash
    Sznewajs, Aimee
    Veatch, Janet
    Huberty, John
    Franc, Benjamin
    Sposto, Richard
    Groshen, Susan
    Wei, Denice
    Fitzgerald, Paul
    Maris, John M.
    Yanik, Gregory
    Hawkins, Randall A.
    Villablanca, Judith G.
    Matthay, Katherine K.
    PEDIATRIC BLOOD & CANCER, 2011, 56 (02) : 191 - 201
12345